{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:57:28Z","timestamp":1765540648507,"version":"3.48.0"},"reference-count":21,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Complementary and Integrative Medicine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective<\/jats:bold>\n                    : We described a case of cerebral venous sinus thrombosis in a patient taking multiple supplements as part of a naturopathic anti-aging regimen.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods<\/jats:bold>\n                    : Case report.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : The patient presented with a thalamic infarct associated with a thrombus in the vein of Galen. He reported no previous history of endocrinopathy and no known hypercoagulability risk factors. He was treated with therapeutic anticoagulation resulting in improvement. Diagnostic workup revealed hyperthyroidism and gonadotrophic deficiency attributed to significant supplement medicine usage.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : This case highlights a potential risk of dietary supplements. Use of these supplements may be a risk factor for idiopathic cerebral venous thrombosis.\n                  <\/jats:p>","DOI":"10.1515\/jcim-2012-0003","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T11:12:34Z","timestamp":1377169954000},"page":"129-134","source":"Crossref","is-referenced-by-count":3,"title":["Iatrogenic venous thrombosis secondary to supplemental medicine toxicity"],"prefix":"10.1515","volume":"10","author":[{"given":"Christopher Ryan","family":"Newey","sequence":"first","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Sarwal","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Medical Center, Winston-Salem, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Tepper","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2013,8,20]]},"reference":[{"key":"2025121209153200609_CIT0001_w2aab3b8c15b1b7b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Orwoll ES, Orwoll RL. Hematologic abnormalities in patients with endocrine and metabolic disorders. Hematol Oncol Clin North Am 1:261\u201379.10.1016\/S0889-8588(18)30675-0","DOI":"10.1016\/S0889-8588(18)30675-0"},{"key":"2025121209153200609_CIT0002_w2aab3b8c15b1b7b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"Horstkamp B. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum Reprod 1996;11:1358\u20139.10.1093\/oxfordjournals.humrep.a019390","DOI":"10.1093\/oxfordjournals.humrep.a019390"},{"key":"2025121209153200609_CIT0003_w2aab3b8c15b1b7b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Horstkamp B, Lubke M, Kentenich H, Riess H, Buscher U, and Lichtengegger W. \u201cInternal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilization. Hum Reprod 1996;11:280\u20132.10.1093\/HUMREP\/11.2.280","DOI":"10.1093\/HUMREP\/11.2.280"},{"key":"2025121209153200609_CIT0004_w2aab3b8c15b1b7b1ab2ab4Aa","doi-asserted-by":"crossref","unstructured":"Squizzato A, Gerdes VE, Ageno W, and Buller HR. The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2007;2:76\u201383.10.1007\/s11739-007-0026-X","DOI":"10.1007\/s11739-007-0026-X"},{"key":"2025121209153200609_CIT0005_w2aab3b8c15b1b7b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Squizzato A, Romualdi E, Buhler HR, and Gerdes VE. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007;92:2415\u201320.10.1210\/jc.2007-0199","DOI":"10.1210\/jc.2007-0199"},{"key":"2025121209153200609_CIT0006_w2aab3b8c15b1b7b1ab2ab6Aa","unstructured":"Jordan S, Murty M, and Pilon K. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. CMAJ 2004;171:993\u20134."},{"key":"2025121209153200609_CIT0007_w2aab3b8c15b1b7b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Bouchard NC, Howland MA, Greller HA, Hoffman RS, and Nelson LS. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clin Proc 2005;80:541\u20135.10.4065\/80.4.541","DOI":"10.4065\/80.4.541"},{"key":"2025121209153200609_CIT0008_w2aab3b8c15b1b7b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"Marongiu F, Conti M, Mameli G, Murtas ML, Balzano S, Sorano G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 11:723\u20135.10.1007\/BF03350928","DOI":"10.1007\/BF03350928"},{"key":"2025121209153200609_CIT0009_w2aab3b8c15b1b7b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Erem C, Ersoz HO, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 25:345\u201350.10.1007\/BF03344016","DOI":"10.1007\/BF03344016"},{"key":"2025121209153200609_CIT0010_w2aab3b8c15b1b7b1ab2ac10Aa","unstructured":"Rogers JS, 2nd, Shane SR. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983;102:444\u20139."},{"key":"2025121209153200609_CIT0011_w2aab3b8c15b1b7b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Navot D, Margalioth EJ, Laufer N, Birkenfeld A, Relou A, Rosler A, et al. Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 1987;48:57\u201361.10.1016\/S0015-0282(16)59290-5","DOI":"10.1016\/S0015-0282(16)59290-5"},{"key":"2025121209153200609_CIT0012_w2aab3b8c15b1b7b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Todorow S, Schricker ST, Siebzehnruebl ER, Neidhardt B, Wildt L, and Lang N. von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome. Hum Reprod 1993;8:2039\u201346.10.1093\/oxfordjournals.humrep.a1379788150900","DOI":"10.1093\/oxfordjournals.humrep.a137978"},{"key":"2025121209153200609_CIT0013_w2aab3b8c15b1b7b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Ozsoylu S, Strauss H, and Diamond LK. Effects of corticosteroids on coagulation of the blood. Nature 1962;195:1214\u20135.10.1038\/1951214a014038141","DOI":"10.1038\/1951214a0"},{"key":"2025121209153200609_CIT0014_w2aab3b8c15b1b7b1ab2ac14Aa","doi-asserted-by":"crossref","unstructured":"Isacson S. Effect of prednisolone on the coagulation and fibrinolytic systems. Scand J Haematol 1970;7:212\u201316.10.1111\/j.1600-0609.1970.tb01890.x5447966","DOI":"10.1111\/j.1600-0609.1970.tb01890.x"},{"key":"2025121209153200609_CIT0015_w2aab3b8c15b1b7b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Jorgensen K, Sorensen P, and Freund L. Effect of glucocorticosteroids on some coagulation tests. Acta Haematol 68:39\u201342.10.1159\/0002069466812355","DOI":"10.1159\/000206946"},{"key":"2025121209153200609_CIT0016_w2aab3b8c15b1b7b1ab2ac16Aa","doi-asserted-by":"crossref","unstructured":"Brotman DJ, Girod JP, Posch A, Jani JT, Patel JV, Gupta M, et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 2006;118:247\u201352.10.1016\/j.thromres.2005.06.00616005496","DOI":"10.1016\/j.thromres.2005.06.006"},{"key":"2025121209153200609_CIT0017_w2aab3b8c15b1b7b1ab2ac17Aa","doi-asserted-by":"crossref","unstructured":"van Giezen JJ, Brakkee JG, Dreteler GH, Bouma BN, and Jansen JW. Dexamethasone affects platelet aggregation and fibrinolytic activity in rats at different doses which is reflected by their effect on arterial thrombosis. Blood Coagul Fibrinolysis 1994;5:249\u201355.10.1097\/00001721-199404000-000158054458","DOI":"10.1097\/00001721-199404000-00015"},{"key":"2025121209153200609_CIT0018_w2aab3b8c15b1b7b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, and Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243\u20138.10.1016\/j.jacc.2005.01.01515837256","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"2025121209153200609_CIT0019_w2aab3b8c15b1b7b1ab2ac19Aa","doi-asserted-by":"crossref","unstructured":"Traber M. Vitamin E and K interactions \u2013 a 50-year-old problem. Nutr Rev 2008;66:624\u20139.10.1111\/j.1753-4887.2008.00123.x19019024","DOI":"10.1111\/j.1753-4887.2008.00123.x"},{"key":"2025121209153200609_CIT0020_w2aab3b8c15b1b7b1ab2ac20Aa","doi-asserted-by":"crossref","unstructured":"Chesney C, Elam M, Herd JA, Davis KB, Garg R, Hunninghake D, et al. Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). Am Heart J 2000;140:631\u201336.10.1067\/mhj.2000.10964811011338","DOI":"10.1067\/mhj.2000.109648"},{"key":"2025121209153200609_CIT0021_w2aab3b8c15b1b7b1ab2ac21Aa","doi-asserted-by":"crossref","unstructured":"Finnegan Y, Howarth D, Minihane AM, Kew S, Miller GJ, Calder PC, et al. Plant and marine derived (n\u20133) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans. J Nutr 2003;133:2210\u201313.10.1093\/jn\/133.7.221012840180","DOI":"10.1093\/jn\/133.7.2210"}],"container-title":["jcim"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2012-0003\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2012-0003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:54:33Z","timestamp":1765540473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jcim-2012-0003\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,6,15]]}},"alternative-id":["10.1515\/jcim-2012-0003"],"URL":"https:\/\/doi.org\/10.1515\/jcim-2012-0003","relation":{},"ISSN":["1553-3840","2194-6329"],"issn-type":[{"type":"electronic","value":"1553-3840"},{"type":"print","value":"2194-6329"}],"subject":[],"published":{"date-parts":[[2013,8,20]]}}}